Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocol.
第一作者:
Dario,Gelevski
第一单位:
Department of Neurology, Sean M. Healey and AMG Center for ALS and the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States.
作者:
医学主题词
美国(United States);人类(Humans);肌萎缩侧索硬化(Amyotrophic Lateral Sclerosis);抗体, 单克隆(Antibodies, Monoclonal);疾病恶化(Disease Progression)
DOI
10.1002/mus.27775
PMID
36533976
发布时间
2023-04-21
- 浏览0
Muscle & nerve
354-362页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



